1. Go RS, Jacobsen E, Baiocchi R, Buhtoiarov I, Butler EB, Campbell PK, et al. Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology. J Nat Comprehen Cancer Netw. 2021;19:1277–303. This article offers a comprehensive overview to the diagnosis of histiocytic neoplasms from diagnosis to treatment.
2. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.
3. Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood J Am Soc Hematol. 2022;140:1229–53.
4. Kemps PG, Picarsic J, Durham BH, Hélias-Rodzewicz Z, Hiemcke-Jiwa L, van den Bos C, et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood J Am Soc Hematol. 2022;139:256–80.
5. Eckstein OS, Picarsic J, Allen CE. Histiocytic disorders of childhood. Pediatr Rev. 2022;43:561–71.